Vishal Navani
9PUBLICATIONS
18CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 03, 2025
Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.Amin H Nassar, Sarah Abou Alaiwi, Talal El Zarif
|Jul 26, 2024
What Is Ailing Oncology Clinical Trials? Can We Fix Them?Abhenil Mittal, Sara Moore, Vishal Navani
|May 24, 2024
New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.David J Stewart, John-Peter Bradford, Sandeep Sehdev
|May 24, 2024
Real-World Analysis of Post-Progression Treatment Patterns and Outcomes for <i>EGFR</i> Mutation-Positive Patients Treated with First-Line Osimertinib.Amanda Jane Williams Gibson, Michelle Liane Dean, Ishjot Litt
|Jan 30, 2024
Progression-Free Survival Gain: A Reliable Primary End Point for Drug Registration That Can Accelerate Patient Access to Urgently Needed Therapies.David J Stewart, Tim Ramsay, Vishal Navani
|Apr 03, 2023
Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.Igor Stukalin, Vishal Navani, Mehul Gupta
Pageof 2
Frequent Collaborators
3 joint publications
Di Maria Jiang
2 joint publications
Moira C Graves
2 joint publications
Nikola A Bowden
2 joint publications
David J Stewart
1 joint publications
Hiren Mandaliya
1 joint publications
Igor Stukalin
1 joint publications
Tim Ramsay
1 joint publications
Amanda Jane Williams Gibson
1 joint publications
Sandeep Sehdev
1 joint publications
Nigel S B Rawson
